In Vivo 36:2022
Enchondromas of the Hand: Curettage with Autogenous Bone vs Bioactive Glass S53P4 for Void Augmentation
.
Lindfors N, Kukkonen E, Stenroos A, Nordback P, Anttila T, Aspinen S
Materials (Basel), August 2021
Dissolution of amorphous S53P4 scaffolds in dynamic in vitro conditions.
Aalto-Setälä L, Uppstu P, Sinitsyna P, Lindfors NC, Hupa L
Acta Biomateriala, 17 March 2021
S53P4 bioactive glass scaffolds induce BMP expression and integrative bone formation in a critical-sized diaphysis defect treated with a single-staged induced membrane technique
E. Eriksson, R. Björkenheim, G. Strömberg, M. Ainola, P. Uppstu, L. Aalto-Setälä, V-M. Leino, L. Hupa, J. Pajarinen, N.C. Lindfors
European Cells & Materials, 9 January 2021
Sintered S53P4 bioactive glass scaffolds have anti-inflammatory properties and stimulate osteogenesis in vitro
R. Björkenheim, E. Jämsen, E. Eriksson, P. Uppstu, L. Aalto-Setälä, L. Hupa, K.K. Eklund, M. Ainola, N.C. Lindfors and J. Pajarinen
2019 IEEE International Ultrasonic Symposium 10.1109/ULTSYM.2019.8925785
Three megapixel ultrasonic microscope imaging. 2019 IEEE International Ultrasonic Symposium
Hyvönen j, Meriläinen A, Salmi A, Hupa L, Lindfors N, Haeggström E.
J Biomed Mater Res Appl Biomed 2019;107:847-857
Bone morphogenic protein expression and bone formation are induced by bioactive glass S53P4
scaffolds in vivo.
Björkenheim R, Strömberg G, Ainola M, Uppstu P, Aalto-Setälä L, Hupa L, Pajarinen J, Lindfors NC.
J Mater Sci 2017;52:9055-9065.
Polymer coated bioactive glass S53P4 increases VEGF and TNF expression in an induced
membrane model in vivo.
Björkenheim R, Strömberg G, Pajarinen J, Ainola M, Uppstu P, Hupa L, Böhling TO, Lindfors NC.
Adv Exp Med Biol 2017;971:81-92.
Bioactive glass S53P4 in the treatment of osteomyelitis – a multinational study.
Lindfors NC, Geurts J, Drago L, Arts JJ, Juutilainen V, Hyvönen P, Suda AJ, Aloj, D, Artiaco S, Alizadeh Ch, Brychcy A, Bialecki J, Romano` C..
Scand J Surg 2016;105:248-253.
Reconstruction of vertebral bone defects using an expandable replacement device and bioactive glass
S53P4 in the treatment of vertebral osteomyelitis – three patients and three pathogens.
Kankare J, Lindfors NC.
Suomen ortopedia ja traumatologia. 2015; 38, 1, s. 59-61
New trends in surgical treatment of chronic osteomyelitis.
Juutilainen V, Lindfors N.
J Biomed Mater Res A 2014;102:4055-4061.
Increase in VEGF secretion from human fibroblast cells by bioactive glass S53P4 to stimulate
angiogenesis in bone.
Detsch R, Stoor P, Grunewald A, Roether JA, Lindfors NC, Boccaccini AR.
Scand J Surg 2012;101:66-71.
Posterolateral spondylodesis using bioactive glass S53P4 and autogenous bone in instrumented unstable lumbar spine burst fracture – A prospective 10-year follow-up study.
Rantakokko J, Frantzen J, Heinänen J, Kajander S, Kotilainen E, Gullichsen E, Lindfors NC.
J Biotech Biomaterial 2011,1:
Clinical aspects on bone remodelling, vascularisation, cartilage repair and antibacterial properties on
bioactive glass S53P4 in reconstructive surgery in the upper extremity.
Lindfors NC.
J Spinal Disord Tech 2011;24:455-461.
Instrumented spondylodesis in degenerative spondylolisthesis with bioactive glass and autologous bone – A prospective 11-year follow-up
Frantzen J, Rantakokko J, Aro HT, Kajander S, Koski I, Gullichsen E, Kotilainen E, Lindfors NC
J Long Term Eff Med Implants 2011;21:139-148.
Bioactive glass S53P4 and autograft bone in treatment of depressed tibial plateau fractures.
Pernaa K, Lindfors NC
Bone 2010;47:212-218.
Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis.
Lindfors NC, Hyvönen P, Nyyssönen M, Kirjavainen M, Kankare J, Gullichsen E, Salo J
J Biomed Mater Res Appl Mat 2010;94:157-164.
A prospective randomized 14-year follow-up study of bioactive glass and autogenous bone as bone
graft substitutes in benign bone tumours.
Lindfors NC, Heikkilä J, Koski I, Mattila K, Aho J.
BONE 2009;45:398-400.
Treatment of a recurrent aneurysmal bone cyst with bioactive glass in a child allows for good
remodellation and growth.
Lindfors NC.
J Biomed Mater Res 2008;90B:131-136.
Bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors.
Lindfors NC, Heikkilä J, Koski I, Mattila K, Aho J.
J Biomed Mater Res 2008;87:73-76.
Long-term evaluation of blood silicon and osteocalcin in operatively treated patients with benign bone
tumours using bioactive glass and autogenous bone.
Lindfors NC, Heikkilä JT, Aho AJ.
J Mat Sci:Mat in Med 2003;14:265-372.
Granule size and composition of bioactive glasses affect osteoconduction in rabbit.
Lindfors NC, Aho AJ.
J Biomed Mater Res 2002;63:237-244.
Bioactive glass as bone substitute for posterior spinal fusion in rabbit.
Lindfors NC, Tallroth K, Aho AJ
J Biomed Mater Res 2001;55:613-627.
Immunoglobuline enhances the bioactive glass induced
chemiluminescence response of human polymorphonuclear leukocytes.
Lindfors NC, Klockars M
Eur Spine J 2000;9:30-35.
Tissue response to bioactive glass and autogenous bone in rabbit spine.
Lindfors NC, Aho AJ.
J Biomed Mater Res 1999;47:91-94.
Bioactive glasses induce chemiluminescence by human polymorphonuclear leukocytes.
Lindfors NC, Klockars M, Ylänen H.